Ideal agent for insomnia not always clear cut
April 14, 2014 | CHEST Physician
Author and Disclosure Information
Dr. Doghramji disclosed that he is a consultant for UCB, Teva Pharmaceuticals, Vanda Pharmaceuticals, and Jazz Pharmaceuticals, and that he holds stock in Merck.
Dr. Paul A. Selecky, FCCP, comments: This is a well written and concise review of the common medications and other agents used in the treatment of insomnia to guide clinicians, pointing out the caution that the non-prescription items have limited scientific evidence to support their regular use. Some of the prescription medications are reviewed as well.
